[CCoE Notice] Submit ideas to help DR-TB patients through COVID-19

[Knudsen, Rachel W]

Dear Faculty,

Please find a COVID-19 related research opportunity detailed below. Please contact us at egrrsrch at uh.edu<mailto:egrrsrch at uh.edu>, if you require assistance or plan on entering this challenge.

Thank you.


From: JLABS QuickFire Challenges <jlabsannouncements at jnjinnovation.com>
Reply-To: "jlabsannouncements at jnjinnovation.com" <jlabsannouncements at jnjinnovation.com>
Date: Tuesday, May 5, 2020 at 11:12 AM
To: "sgghurye2 at uh.edu" <sgghurye2 at uh.edu>
Subject: Submit ideas to help DR-TB patients through COVID-19

Introducing the Drug-Resistant Tuberculosis Lifeline QuickFire Challenge
Images missing? View this email as a web page here<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*N2QqZvdy-jLrW3k-RZP4XPvrV0/5/f18dQhb0S1Xm2p4p3bV1vjjH1LvYvWW5TjRCn2wf0-hW40Jhtc7dr8SjW3qhzm-7NbnTpW4RLvx_4rrysqW8rgmB54vDwwlMjPzDXnsP0QW6_TVZr2q5vSbW74jZMk4sHDQMW8QwrQQ96DpCTW96G1bp84Ml5DVMLZv47NfdzjW4s-yJP43rBjyW8hS7P41lzhK-W6358n62lTk9wN4hsfv7M4yZvW6kpBjq5SMPXZMHx6WSHw8PTN1vpNHR4kvb5Vn5Psc3qHYYXW4ZFYdM6GpF6WW65TrN37C74fBW2F2NFD2g-JgwW2b4n142y6TNVN8mJ2XyrTb4VW92DtMF73NtS4VHBQXW7trK23W7MLf-971qjmfW4YWsgt4L_kYVW42VxbV5qN1y-W7M6TNy8hM6WdW8jqZlR4_NPltW45Dl_k3bj4zfW2XNq5y7VdcKWW2wlvsX7rPKjgVMBnBf8pr1ZMVQWVJ85RXGbHW7rNHYm80W4WMW5F5npV3NY3w8W7Lbt_R4jDjCPW222Tg63Hhb0fW9bvnx9337hwFW65JmCS2_hKXvW13F1Dd2VrB5fW5T3_6N4wHDKlW3VSPvZ1xyR7xW1LRGDz1x3-WcW2MBFFt2rLj3MW7c4ggw4rpb3zW3bHFTw3925ybW9k1W337n6YqmN44xyJ5TLR04W2bl3g66nPz8DW9gRsFg2SG_WHVMm8qm76lPxZf7dHC8j04>.
[Johnson & Johnson Innovation | JLABS]<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*W1Mxnpt3LXR_XW7mGWBY5rYCdz0/5/f18dQhb0Sjvg8XJ93YN9blz-RHyjJqMS9QBMcV_FzN3hHh9fXL0jYVnQ9Qq8-PyjTW5p683W8TTnPrW8VmgwW2Mn9WVW8Yztwf8_dDryW4bJ02h4b_rKwW7MbC3Q4NpqrFW34RCjx1Thgy_W1TxBMp7t09YLW1Z66Qk8hTJV4W8lwVXY8hS296W7bj1-t2zfyqdW7NrMZs3ndfYDW5DFWr25mKjF6W3m2qD12x-ccwW7d094f6G7FblW4DFfS36R8533W2JjCKb4WYsWbW41h__n3KV8MgVPfcgT8n_JjtW9hhZLc16V2c4W2TSfg62nwnXdW95Tx3Z515HWqW95Bvzl1cfnxTW1qkcYp4M2L_dW2-7B6g3g2D17W5bq5LG1xfdB-W1qs7Jw4KRkXHW4KP5BH1VtdWZW2kL7-522TNxnV9Mb5m471w-wW66jlZR36_zVBW5qQJly64HjKdW2GD9D74bFcn1W1ZmmDj5RwQn6Vp3cVy4B3p4BW7cXXm49fTwSGW5D9n0M5V9WFRW3f5_rb15Mdzkf2F3MK-04>
QUICKFIRE CHALLENGE BRIEF
[h_DR-TB-LifelineQFC-01]<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*W8QFFC731QrXRW66bsKt3Py1FY0/5/f18dQhb0S1Xm28_NrPSmL51fV-cTW2pvMj84-wvsTN5dyxxPjszWsW4NT5KY30Q-N8W7V-x543T3q-yW6DBH424PdF0HW8bKrd_4Gs78nW8S-z6p2pZqRXW10Mtxl41kWs5W9cnFPC1sW7W9W2HCM4v8SRFmpW2dxTrw5w3nqDW2DqfvM2RNylXW7VRZW_3QPTb8W4pq7j15Tj4sRW4hrkCC2PyWPTW4WwGc727K9wLW2qCD-v65112vW8bRjwJ8364xnW6f9Wm66VkMN4W8Cs0PN9hw6MlW7GTlq02d6QGvN6tXmPc-9FKFW1frQLP467rXqW5BMdFF1wzY0_N6mzfxzskfFkW5Vt3fn2kj9D1W6mnZmh1f6g3cW7S35Tw5KgtZ9W5X9mH16K-vrHW4tRJS9344sq6W1sz8nX2PGtMrW15TT-216PfkBW7qWyX73tRFWRW81Pf5b6hgrgDW89b9h85T0b4YW3kxmKx5YGBc5N95K0C0Pgs9CW7JS4Mc2RwJbVVW7mDc77PkwQW7HdTjs9kJfrKW65vnQk498mYpW5RrPks6GS9V-W5kqPWV7j4WWHN5yXJ2s7Txmwf18mW0511>
SEEKING IDEAS AIMING TO HELP DRUG RESISTANT-TUBERCULOSIS PATIENTS THROUGH COVID-19
[Enter the challenge]<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*W5SxRBS1v8zW5W66nCMD8HtSxC0/5/f18dQhb0S1W973FkvWV12kqR1MNfhkVnnZn06Cc9RlN2Syz5w9y-1wW31vf782NFxW7W5hBdf06pBCp-W924qX76T0RwCMkw3WJnsP0QW9k8C6P129BySW2nkL7q21-dMLW8hZjgc8fR1KBW8Lk4-V5DRTrdW4X5LTR5P6cw1VZ3GGB4JGV8ZW24z_PL2ygqwtMQYt4RftS0fW5q9vZY6RqhbVVTQmzl1c6X4HW11MhSt79ppnGW3pdT4s524mjGW3yHwQq6hNcmPW6klG1V3n8bBTW8QBSZ434mSycW6xsKgn3dLM4yW1sMxZM6RFGHqW4Qh4_b5HXwhNW7--G2z83DnFCW1q4F8g3RmclcW8qzPw07k-JcBW5xq8H91bJ-58W5XrVzv2gzs3qN4kKPB442rCzW6NWWr27cVMPxW7hfq9w4LGzRqW8dRb1b33Sv3qW6BMjMg4hjqzCV4nxNR19DSzQMdHbNWVhQxgW76Vx5b5b8w25W4wjpRL5DVfdlW7Xd16c76CwCWV8mHZ98-YD6pW1NPXXY510pQFW61Crfm5f83LYW6F-9nW3fWgNPW35pvZW71fKn1W87tM4l3jGtSsW6tDzQc5kSfs3W8D9k3z1BVzxdW66mfgS3_QlB8W3pVLSz1cXSdqW7j1R7r1GK-H6W6jz7L92fJpgvW99BS476xXZP8W2xK1m46HL6hFVxVzXt6n0V4tW13855T63S39zW5W92rC1Y7C0nW6XSRD_7VVbB5W2WmFvZ4GKWphW4zDSC36TC24LW2C4mnc6zPlp5W4m-hH85Rhw6LN6khKw-Dz6wq0>
Submission deadline: May 19, 2020

Dear Shilpa,

The COVID-19 pandemic is wreaking havoc the world over, having a devastating impact on the health of the most vulnerable, including those living with drug-resistant tuberculosis (DR-TB). Prior to COVID-19, only an estimated 1 in 5 patients with drug-resistant tuberculosis successfully navigated their care.

COVID-19 presents new challenges and concerns. Patients and survivors with respiratory impairment and/or lung damage may be more vulnerable to serious complications from COVID-19 – and the pandemic has seriously disrupted and weakened already-fragile systems of delivering care to DR-TB patients.

To that end, we're seeking innovative proposals for creative, easy-to-implement ideas – that can start having impact immediately – aiming to ensure continuity of DR-TB care for patients in high-burden countries (e.g., India, Indonesia, Philippines, South Africa, Ukraine). Specifically, we are looking for ideas that address one or more of the following areas:

  *   Remote consultations and follow-up
  *   Home-based and/or digital patient support for sustaining TB treatment adherence & completion
  *   Access to care for adverse events without leaving the home
  *   Connections to support mental health, nutrition, address social isolation, and peer-to-peer support as well as social benefits

Rewards and benefits

  *   Up to five innovators with the best ideas, technologies, or potential solutions could be awarded grant funding from a total of $250,000*.
  *   Engagement with experts at the Johnson & Johnson Family of Companies to make ideas reality

*Up to $50,000 in grant funding each for up to five awardees

Don't miss out!
[Enter the challenge]<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*TZzFS8vzD3sW8bnCNB1F2P0p0/5/f18dQhb0S1W97Bf-yvV1xZQ61MNfhkVnnZn06Cc9RlN2SyV01ChnGdW2MRJrR1Dy2L-W2s59nK61mts7N87SpH6SwMDqW7402Bh74n6fdN4HjYdZ6xX-wW2GyVrg3M9GX2W96Q8PV8fR1KBW8Lk4-V5DRTrdVf7k4z7BCfMVW2C1Gnf1hlqHJW5cbqWP9gP_5BVqc-cb2f9QZTN1pwx1NSzwNnV563KQ8NPV6kVgPdNQ8gfbccW1JDtWj7bC62BW6zjDB-7Sr6wKW38XFjQ6G8PVYW5Kk3KZ52C2MsW5wLgqT8CjnSpW1lf7Zk10JcYYW19mbFd3HzRngW3Lt0z19b6fVcW4L8yGv6l-6L7W3plKKr1S_7ftN7rN0WWD3nnmW67Y9Z25dc3wxN15qtpmzTkQRW354zF93f0CDVW50tMpg5S-vdmW4g4Kn-1xkX4CW3lBGPK27GcdYV3jDVZ4y4NLRN27gCP2Vj0NNW2pffLc1-tC73W8F6y1N5FmVhPN7WKBdkhvj_QVC0zz15sbPVpN3wF76nFR86dW2K5nJ415JwccW3WSYtZ6xBq_7W6bLGZg4LmW2hW6XT1SF6CkHH4W3FgzQC1jNsglW7SgFjC38Br61W7fBv-_3_L_BZW1p9d7F5gNKzNW3F1Cck1G8BBjW8k46YY5cTlHJW4BQ6Lw5VBs_nW5X0-D73lTbx6W4Z-_wX3cbK0_W128zk163S2tFW5Wp69G1Y7C0nW6XSRD_7VVbB5W2WmFvZ4GKWphW4zDSC36TC24LW4vHNyS6zPlp5W4m-hHp2ht7hkV2by3w2M6304103>
Submission deadline: May 19, 2020

© Johnson & Johnson Innovation - JLABS 2020.
3210 Merryfield Row | San Diego, CA  92121 | USA
You received this email because you are subscribed to QuickFire Challenges Brief from Johnson & Johnson Innovation - JLABS.
Update your profile<https://h8.t.hubspotemail.net/e2t/c/*W3WldZQ95lBLyW69rNVC7fbKRC0/*W827D7C6ZnSXVW4ClZHY7cfYC80/5/f18dQhb0Sq5w8Y9YL6W91Bh4f1m4DtzN1Fp3N2rNzQwW6Blznq1Nvw7TVM7Yn33P_FKFVQfs7G3K3C2XW8p01fH3J4LTNV-0dcq5zCGcRW3JrV-P3Pn-sqW8B-9dc8zTLsMW1lbmPY8qtS8vVNdwst8r4j9HW7Xm5Gq7d-tJnVQJ99n8tsRDgN8xN8V7Zw0N6W64QM5T8r4lkQW4LnCgK19yTFSW625bx16Gj8TSW6bVy-525cnVbW7NrMZs3ndm6jW49WVtr3VVg3wW8clvBZ3X0g0yN6bp1cMbq5fxW4TKc2l5v8wcQW61PH_82zGHRTW1cWstV7yCPbDW3Sld2N5vG34YVF2KVd7ZMqbbW4s18rV1cNKn1W2HtY7V3N2_j5N1mdNcwFSJRlW6mwBzt7c-B4SW1x6bC125KhgzW15mXjS6ph5yxW6-kvsX1p7-fwW1bBvW33_5Xh9W6LM3H41NFfl4N8P4pWykXwM3W3PmX3763LC-4W3N2z0g5q55vCW7mt3V-83PYShW3L1_nc3NxBMTW6j9FDL21vs0JW5RcZzp3b1nlJW66Q3fg73yKD2W70RWLM6tLtWs111> to choose the types of emails you receive, or unsubscribe from future emails<https://hs-3988599.s.hubspotemail.net/hs/manage-preferences/unsubscribe?d=Vnbsj76MXH38VCsNKB3R5JYDW3JH5dN3Qz74WW4h26H75DV1txVmWcP36R3jbfN6cnjjD25tWbW5b2lg57HhZCHW5fQ6Bl5P5v-1V1yf0N31nDr3W5tX6vW3fYxRfW7pdNQP14YVvw21q3&v=3&utm_campaign=DR-TB%20Lifeline%20QFC&utm_source=hs_email&utm_medium=email&utm_content=87440018&_hsenc=p2ANqtz-9hjbuHH122-FTvGvCy1xfx2w9jtOXRgHkC2Bnu7RTz-oblsa6gEotH4TXeD4EhrQsu5ZdI8jlUZAH8WdEO34M-uQ48HQ&_hsmi=87440018>





-------------- next part --------------
An HTML attachment was scrubbed...
URL: http://Bug.EGR.UH.EDU/pipermail/engi-dist/attachments/20200505/5391a0a8/attachment-0001.html